Hello, I would like to hear Your opinions on Dr. Frank Comhaire's recent studies and findings. He is guessing that this nutriceutical could help improving symptoms to about 30% of people with ME/CFS. He developed a formula to predict which groups of the patients could benefit from the supplement and which groups would probably not experience reasonable benefits. What is Your say on this? Could this turn out to be something new and perspective in the nearby future ? Could this appear on the market openly as a legitimate help for those, who need it ? You can read the studies here: 1. A Novel Nutriceutical Treatment of Myalgic Encephalitis/Chronic Fatigue Syndrome (ME/CFS): “What it is and what it is not” 2. Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial Thank You for Your time.